-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Smith & Nephew Plc (LON:SN) Receives GBX 1,418.60 Consensus PT From Analysts
Smith & Nephew Plc (LON:SN) Receives GBX 1,418.60 Consensus PT From Analysts
Smith & Nephew plc (LON:SN – Get Rating) has been assigned a consensus rating of "Moderate Buy" from the six research firms that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is GBX 1,418.60 ($17.14).
Several research firms recently commented on SN. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a GBX 1,500 ($18.12) price objective on shares of Smith & Nephew in a research report on Tuesday, September 13th. JPMorgan Chase & Co. lowered their price target on shares of Smith & Nephew from GBX 1,442 ($17.42) to GBX 1,243 ($15.02) and set a "neutral" rating on the stock in a research note on Thursday, August 4th. Barclays lowered their price target on shares of Smith & Nephew from GBX 1,630 ($19.70) to GBX 1,550 ($18.73) and set an "overweight" rating on the stock in a research note on Thursday, August 4th. Credit Suisse Group lowered their price target on shares of Smith & Nephew from GBX 1,540 ($18.61) to GBX 1,400 ($16.92) and set an "outperform" rating on the stock in a research note on Thursday, August 4th. Finally, Berenberg Bank lowered their price target on shares of Smith & Nephew from GBX 1,800 ($21.75) to GBX 1,400 ($16.92) and set a "buy" rating on the stock in a research note on Thursday, September 8th.
Get Smith & Nephew alerts:Smith & Nephew Trading Down 0.6 %
SN opened at GBX 1,004.50 ($12.14) on Friday. The stock has a market capitalization of £8.75 billion and a P/E ratio of 2,050.00. Smith & Nephew has a 12 month low of GBX 994.80 ($12.02) and a 12 month high of GBX 1,379.60 ($16.67). The firm's fifty day simple moving average is GBX 1,075.14 and its 200 day simple moving average is GBX 1,172.99. The company has a current ratio of 1.78, a quick ratio of 0.84 and a debt-to-equity ratio of 53.62.
Smith & Nephew Cuts Dividend
The company also recently disclosed a dividend, which will be paid on Wednesday, October 26th. Stockholders of record on Thursday, September 29th will be paid a dividend of $0.14 per share. The ex-dividend date of this dividend is Thursday, September 29th. This represents a dividend yield of 0.99%. Smith & Nephew's dividend payout ratio is presently 6,122.45%.Insider Transactions at Smith & Nephew
In related news, insider Erik Engstrom bought 332 shares of Smith & Nephew stock in a transaction that occurred on Tuesday, August 23rd. The stock was acquired at an average price of GBX 1,010 ($12.20) per share, with a total value of £3,353.20 ($4,051.72).
About Smith & Nephew
(Get Rating)
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.
Featured Stories
- Can Caterpillar Claw Higher in a Falling Market?
- Is Dave & Buster's Immune to High Inflation and Lower Spending?
- Should These 3 Top-Performing Mid-Caps Be On Your Watchlist?
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.
Smith & Nephew plc (LON:SN – Get Rating) has been assigned a consensus rating of "Moderate Buy" from the six research firms that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is GBX 1,418.60 ($17.14).
据MarketBeat报道,Smith&Nephew plc(LON:SN-GET Rating)已被目前追踪该公司的六家研究公司一致评为“中等买入”。三名投资分析师对该股的评级为持有,三名分析师对该公司的评级为买入。去年更新了该股覆盖范围的券商的平均12个月目标价为1,418.60英镑(合17.14美元)。
Several research firms recently commented on SN. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a GBX 1,500 ($18.12) price objective on shares of Smith & Nephew in a research report on Tuesday, September 13th. JPMorgan Chase & Co. lowered their price target on shares of Smith & Nephew from GBX 1,442 ($17.42) to GBX 1,243 ($15.02) and set a "neutral" rating on the stock in a research note on Thursday, August 4th. Barclays lowered their price target on shares of Smith & Nephew from GBX 1,630 ($19.70) to GBX 1,550 ($18.73) and set an "overweight" rating on the stock in a research note on Thursday, August 4th. Credit Suisse Group lowered their price target on shares of Smith & Nephew from GBX 1,540 ($18.61) to GBX 1,400 ($16.92) and set an "outperform" rating on the stock in a research note on Thursday, August 4th. Finally, Berenberg Bank lowered their price target on shares of Smith & Nephew from GBX 1,800 ($21.75) to GBX 1,400 ($16.92) and set a "buy" rating on the stock in a research note on Thursday, September 8th.
几家研究公司最近对SN发表了评论。9月13日,周二,加拿大皇家银行在一份研究报告中重申了行业表现评级,并对Smith&Nephew的股票发布了1500英镑(18.12美元)的目标价。8月4日,摩根大通在一份研究报告中将Smith&Nephew的股票目标价从1,442英镑(合17.42美元)下调至1,243英镑(合15.02美元),并将该股的评级定为“中性”。8月4日,巴克莱在一份研究报告中将Smith&Nephew的股票目标价从1,630英镑(19.70美元)下调至1,550英镑(18.73美元),并将该股的评级定为“增持”。瑞士信贷集团将Smith&Nephew的股票目标价从1,540英镑(18.61美元)下调至1,400英镑(16.92美元),并在8月4日(星期四)的一份研究报告中设定了该股的“跑赢大盘”评级。最后,贝伦伯格银行在9月8日星期四的一份研究报告中将Smith&Nephew的股票目标价从1,800英镑(21.75美元)下调至1,400英镑(16.92美元),并对该股设定了买入评级。
Smith & Nephew Trading Down 0.6 %
Smith&Nephew股价下跌0.6%
SN opened at GBX 1,004.50 ($12.14) on Friday. The stock has a market capitalization of £8.75 billion and a P/E ratio of 2,050.00. Smith & Nephew has a 12 month low of GBX 994.80 ($12.02) and a 12 month high of GBX 1,379.60 ($16.67). The firm's fifty day simple moving average is GBX 1,075.14 and its 200 day simple moving average is GBX 1,172.99. The company has a current ratio of 1.78, a quick ratio of 0.84 and a debt-to-equity ratio of 53.62.
上周五,SN的开盘价为1004.50英镑(合12.14美元)。该股市值为87.5亿GB,市盈率为2050.00倍。Smith&Nephew的12个月低点为994.80英镑,12个月高点为1,379.60英镑。该公司的50日简单移动均线为1,075.14英镑,其200天简单移动均线为1,172.99英镑。该公司的流动比率为1.78,速动比率为0.84,债务权益比率为53.62。
Smith & Nephew Cuts Dividend
Smith&Nephew削减股息
Insider Transactions at Smith & Nephew
Smith&Nephew的内幕交易
In related news, insider Erik Engstrom bought 332 shares of Smith & Nephew stock in a transaction that occurred on Tuesday, August 23rd. The stock was acquired at an average price of GBX 1,010 ($12.20) per share, with a total value of £3,353.20 ($4,051.72).
在相关新闻中,内部人士埃里克·恩斯特罗姆在8月23日(星期二)的一笔交易中购买了332股Smith&Nephew股票。收购股票的平均价格为每股1,010英镑(12.20美元),总价值为3,353.20英镑(4,051.72美元)。
About Smith & Nephew
关于Smith&Nephew
(Get Rating)
(获取评级)
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.
Smith&Nephew plc及其子公司在全球范围内开发、制造、营销和销售医疗器械。该公司提供用于膝关节置换手术的膝关节植入物产品;用于重建髋关节的髋关节植入物;以及包括用于稳定严重骨折和畸形矫正程序的内部和外部设备的创伤和肢体产品。
Featured Stories
专题报道
- Can Caterpillar Claw Higher in a Falling Market?
- Is Dave & Buster's Immune to High Inflation and Lower Spending?
- Should These 3 Top-Performing Mid-Caps Be On Your Watchlist?
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- 卡特彼勒能否在下跌的市场中走得更高?
- Dave&Buster‘s能免受高通胀和低支出的影响吗?
- 这三只表现最好的中型股应该出现在你的观察名单上吗?
- 华尔街对Datadog的热情会带来巨大的收益吗?
- MarketBeat:回顾一周9/19-9/23
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.
接受Smith和Nephew Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Smith&Nephew和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧